With the increasing lifespan of people living with HIV (PLWH), frailty and prefrailty are becoming topics which require more attention. The reciprocal interactions between chronic inflammation, comorbidities and frailty demonstrate the complex pathophysiology of frailty and its consequences. Female sex, HIV infection without antiretroviral treatment, reduced CD4 cell count, depression and cardiovascular disease are some of the risk factors for frailty among PLWH. Frailty predisposes to falls and can therefore lead to more frequent fractures, hospitalization and death, especially in women with osteoporosis. Continuous antiretroviral treatment, prevention of comorbidities such as depression and diagnosis of prefrailty are crucial interventions to slow the development of frailty. This review summarizes the literature on frailty in people living with HIV and discusses frailty management strategies in order to improve the health outcomes in women living with HIV.
JonesHTLevettTBarberTJ. Frailty in people living with HIV: An update. Curr Opin Infect Dis2022; 35: 21–30.
3.
FalutzJBrañasFErlandsonKM. Frailty: The current challenge for aging people with HIV. Curr Opin HIV AIDS2021; 16: 133–140.
4.
FranceschiCCampisiJ. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci2014; 69: 4–9.
5.
HubbardREO'MahonyMSSavvaGM, et al.Inflammation and frailty measures in older people. J Cell Mol Med2009; 13: 3103–3109.
6.
van HallGSteensbergAFischerC, et al.Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab2008; 93: 2851–2858.
7.
LengSChavesPKoenigK, et al.Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc2002; 50: 1268–1271.
8.
FriedLPTangenCMWalstonJ, et al.Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001; 56: 146–156.
9.
SinghTNewmanAB. Inflammatory markers in population studies of aging. Ageing Res Rev2011; 10: 319–329.
10.
MezukBEdwardsLLohmanM, et al.Depression and frailty in later life: a synthetic review. Int J Geriatr Psychiatry2012; 27(9): 879–892.
11.
LohmanMDumenciLMezukB. Depression and Frailty in Late Life: Evidence for a Common Vulnerability. J Gerontol B Psychol Sci Soc Sci2016; 71(4): 630–640.
12.
VaughanLCorbinALGoveasJS. Depression and frailty in later life: a systematic review. Clin Interv Aging2015; 10: 1947–1958.
13.
YamadaYKobayashiTCondoA, et al.Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis. Open Forum Infect Dis2022; 9: 129.
14.
GustafsonDRShiQThurnM, et al.Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women-The Women's Interagency HIV Study. J Frailty Aging2016; 5: 43–48.
15.
UmblejaTBrownTTOvertonET, et al.Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE. J Infect Dis2020; 222: 52–62.
16.
ZhangXHuYJusticeAC, et al.DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty. Nat Commun2017; 8: 2243.
17.
VeroneseN. Frailty as Cardiovascular Risk Factor (and Vice Versa). Adv Exp Med Biol2020; 1216: 51–54.
18.
GuaraldiGOrlandoGZonaS, et al.Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis2011; 53(11): 1120–1126.
19.
DeeksSG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med2011; 62: 141–155.
20.
SerrãoRPiñeroCVelezJ, et al.Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study. Int J Infect Dis2019; 79: 94–100.
21.
McMillanJMGillMJPowerC, et al.Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes. AIDS Patient Care STDS2020; 34(7): 284–294.
22.
KuniholmMVásquezEAppletonA, et al.Cardiovascular risk score associations with frailty in men and women with or at risk for HIV. AIDS2022; 36: 237–347.
23.
SoysalPVeroneseNThompsonT, et al.Relationship between depression and frailty in older adults: A systematic review and meta-analysis. Ageing Res Rev2017; 36: 78–87.
24.
OyonJSerra-PratMLimonE, et al.Depressive symptom severity is a major risk factor for frailty in community-dwelling older adults with depression. A prospective study. 2022: 174.
25.
OyonJSerra-PratMFerrerM, et al.Psychosocial factors associated with frailty in the community-dwelling aged population with depression. A cross-sectional study. Aten Primaria2021; 53: 102048.
IanasVBergEMohlerMJ, et al.Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care2013; 12: 62–66.
28.
MeloGCCarvalhoACAMendesMLT, et al.Association between frailty phenotype, quantification of plasma HIV-1 RNA, CD4 cell count and HAART in HIV-positive subjects: a systematic review and meta-analysis of observational studies. AIDS Care2021; 34: 1–10.
29.
OgburnDFSchoenbachVJEdmondsA, et al.Depression, ART Adherence, and Receipt of Case Management Services by Adults with HIV in North Carolina, Medical Monitoring Project, 2009-2013. AIDS Behav2019; 23(4): 1004–1015.
30.
BiverE. Osteoporosis and HIV Infection. Calcif Tissue Int2022; 11: 624–640.
31.
MathadJSGupteNBalagopalA, et al.New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr2016; 73(2): 123–129.
32.
ÁlvarezSBrañasFSánchez-CondeM, et al.Frailty, markers of immune activation and oxidative stress in HIV infected elderly. PLoS One2020; 15(3): e0230339.
33.
MuyanjaDMuzooraCMuyingoA, et al.High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda. AIDS Patient Care and STDs; 30: 1–10.
34.
KrollAFSprinzELealSC, et al.Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in Porto Alegre, Brazil. Arq Bras Endocrinol Metabol2012; 56(2): 137–141.
35.
DingYLinHLiuX, et al.Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms. J Infect Dis2017; 215(5): 687–692.
36.
García-EsquinasEJosé García-GarcíaFLeón-MuñozLM, et al.Obesity, fat distribution, and risk of frailty in two population-based cohorts of older adults in Spain. Obesity (Silver Spring)2015; 23(4): 847–855.
37.
GustafsonDRShiQHolmanS, et al.Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women's Interagency HIV Study. BMJ Open2017; 7(6): e013993.
38.
AshrafANOkhaiHSabinCA, et al.Obesity in women living with HIV aged 45-60 in England: An analysis of the PRIME study. HIV Med2022; 23(4): 371–377.
39.
WaldronEMBurnett-ZeiglerIWeeV, et al.Mental Health in Women Living With HIV: The Unique and Unmet Needs. J Int Assoc Provid AIDS Care2021; 20: 2325958220985665.
40.
de BoerMGvan den BerkGEvan HoltenN, et al.Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice. AIDS2016; 30: 2831–2834.
41.
HoffmannCScheweKFenskeS, et al.Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice. Antivir Ther2020; 25(2): 83–90.
42.
CohenMHHottonALHershowRC, et al.Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women. J Acquir Immune Defic Syndr2015; 70(5): 538–544.
43.
DuffPMoneyDOgilvieG, et al.Severe menopausal symptoms associated with reduced adherence to antiretroviral therapy among perimenopausal and menopausal women living with HIV in Metro Vancouver. Menopause2018; 25(5): 531–537.
44.
AndanyNKaidaAde PokomandyA. Prevalence and correlates of early-onset menopause among women living with HIV in Canada. Menopause2020; 27: 66–75.
45.
BullingtonBWEdmondsARamirezC, et al.Premature and early menopause among US women with or at risk for HIV. Menopause2022; 29(6): 741–747.
46.
WeitzmannMNOfotokunITitanjiK, et al.Bone Loss Among Women Living With HIV. Curr HIV/AIDS Rep2016; 13: 367–373.
47.
LiGThabaneLPapaioannouA, et al.An overview of osteoporosis and frailty in the elderly. BMC Musculoskelet Disord2017; 18: 46.
48.
SharmaAShiQHooverDR, et al.Frailty predicts fractures among women with and at-risk for HIV. AIDS2019; 33: 455–463.
49.
ApóstoloJCookeRBobrowicz-CamposE, et al.Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep2018; 16(1): 140–232.
50.
GaleCRBaylisDCooperC, et al.Inflammatory markers and incident frailty in men and women: the English Longitudinal Study of Ageing. Age (Dordr)2013; 35(6): 2493–2501.
51.
ZhangWLiHBreamJH, et al.Longitudinal association of cytokine-producing CMV-specific T cells with frailty in HIV-infected and -uninfected men who have sex with men. Immun Ageing2022; 19: 13.
